Cross-talk between adenosine and opioid receptors

Jason N Peart1, Garrett J Gross

  • 1Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. jpeart@mcw.edu

Insights

Opioid and adenosine receptors interact, influencing protection against ischemic injury in the brain and heart. Blocking one receptor family can negate the protective effects of the other.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cardiovascular Physiology

Background:

  • Opioid and adenosine receptors are G-protein-coupled receptors involved in various physiological and pathophysiological processes.
  • Both receptor families offer protection against ischemic injury in the central nervous system (CNS) and myocardium.
  • Existing research suggests a significant interaction between opioid and adenosine receptor signaling pathways.

Purpose of the Study:

  • To review and highlight research demonstrating the interaction between opioid and adenosine receptors.
  • To explore how this interaction impacts protection against ischemic injury in the CNS and myocardium.

Main Methods:

  • Literature review of studies investigating opioid and adenosine receptor interactions.
  • Analysis of research data from both central nervous system and myocardial studies.
  • Examination of receptor sensitivity alterations and endogenous adenosine release in response to morphine.

Main Results:

  • Evidence indicates a close interplay between opioid and adenosine receptors, affecting receptor sensitivity and endogenous adenosine levels.
  • The cardioprotective effects mediated by adenosine can be diminished by opioid receptor antagonists, and vice versa.
  • This interaction is observed in both central nervous system and myocardial tissues.

Conclusions:

  • Opioid and adenosine receptors exhibit a significant functional interaction.
  • This interaction plays a crucial role in the protective mechanisms against ischemic injury in the brain and heart.
  • Further research into this receptor crosstalk may reveal novel therapeutic strategies for ischemic conditions.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...